Scripps Clinic

La Jolla, California 92307

2 studies enrolling now · 119 studies all time

What they study most

Acute Alcoholic Hepatitis, Acute Hepatitis, Acute Liver Failure, Acute on Chronic Hepatic Failure, Adult Solid Tumor, Angina, Aortic Stenosis, Arthritis, Rheumatoid, Atrial Fibrillation, Back Pain, Basal Cell Carcinoma, Bleeding

Studies at this site

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) — Recruiting now
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care — Recruiting now
TNBC Gut Microbiota During Neoadjuvant Treatment — Recruiting now
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have — Running, not enrolling
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) — Running, not enrolling
ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement — Running, not enrolling
Prospective, Multi-Center Adult Spinal Deformity Outcomes Database Registry — Running, not enrolling
RESPONDER-HF Trial — Running, not enrolling
Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO) — Completed
Stress CMR Perfusion Imaging in the United States (SPINS) Study — Completed
BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia — Completed
Postoperative Pain Control in Total Shoulder Arthroplasty — Completed
Zoster Eye Disease Study — Completed
An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers — Completed
Entyvio (Vedolizumab) Long Term Safety Study — Completed
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis — Completed
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006) — Completed
Ventral Hernia Study Using OviTex Reinforced Bioscaffold — Completed
Disrupt CAD III With the Shockwave Coronary IVL System — Completed
A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation — Stopped early
REDUCE LAP-HF TRIAL II — Running, not enrolling
Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) — Stopped early
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin — Completed
Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis — Completed
An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant — APPROVED_FOR_MARKETING
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement — Stopped early
aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation — Status unconfirmed
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer — Stopped early
Molecular Biomarkers in Renal Transplantation Via TruGraf® Test — Status unconfirmed
Prasugrel/Clopidogrel Maintenance Dose Washout Study — Completed
An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) — Completed
GLORIA-AF Registry Program - Second and Third Phases — Completed
A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer — Stopped early
Spinal Cord Stimulation With Precision® System Versus Reoperation for Failed Back Surgery Syndrome — Stopped early
Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) — Completed
Arsenic Trioxide in Treating Patients With Multiple Myeloma — Stopped early
Dapagliflozin And Pulmonary Artery Hemodynamics in Heart Failure With Reduced Ejection Fraction Patients With CardioMEMS® — Status unconfirmed
Insulin Resistance Intervention After Stroke Trial — Completed
Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer — Completed
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV — Completed
Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial — Completed
Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC) — Completed
Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis — Completed
Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis — Completed
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions — Completed
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL) — Completed
An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis — Withdrawn before enrolling
Study of New Implantable Loop Recorder — Completed